Revenue growth is due to growth in Teva's US generics business, the company's main market, among other things due to sales of ...
I have long held the belief that digital therapeutics will be prescribed alongside drugs to improve patient outcomes, leading ...
In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price target of $25.00. The company’s shares closed last Friday ...
Pennsylvania was involved in a coalition of 50 states and territories that have settled with the generic prescription drug ...
Jurors in Baltimore will decide if two drug companies should pay the city over $260 million in damages for allegedly contributing to its opioid crisis.
Experts share their easy tips for saving on prescriptions. One of the easiest ways to save money on meds is to ask your ...
high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices ...
Neurocrine Biosciences, Inc.'s potential for growth in the biopharma sector is strong despite recent setbacks, making its ...
Last week, the European Commission announced that it had imposed a half-a-billion dollar fine on Teva , a multinational <a target= ...
TEVA reports better-than-expected third-quarter results, beating both earnings and sales estimates. However, the stock declines 7%.
In terms of liquidity and interest, the mean open interest for Teva Pharmaceutical Indus options trades today is 8263.67 with ...